Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.

Saved in:
Bibliographic Details
Title: Novel therapies in myeloid neoplasms show limited benefit and increased costs over 15 years of follow-up in Southern Finland.
Authors: Lanamtieng T; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. theerin.lanamtieng@helsinki.fi., Mervaala-Muroke A; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland., Toivanen L; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland., Porkka K; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland.; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Brück O; Hematoscope Lab, Comprehensive Cancer Center, Department of Oncology, Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki University Hospital, University of Helsinki, Tukholmankatu 8C, Helsinki, P.O. Box 705, FIN-00290, Finland. oscar.bruck@hus.fi.
Source: Annals of hematology [Ann Hematol] 2026 Feb 06; Vol. 105 (3), pp. 94. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first